SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-23-079147
Filing Date
2023-09-25
Accepted
2023-09-25 16:12:21
Documents
15
Period of Report
2023-09-25
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea185755-8k_inmedpharm.htm   iXBRL 8-K 43570
2 SEDAR FILING SUBMITTED SEPTEMBER 25, 2023 ea185755ex99-1_inmedpharm.htm EX-99.1 7008
7 GRAPHIC ex99-1_001.jpg GRAPHIC 4355
  Complete submission text file 0001213900-23-079147.txt   273604

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE inm-20230925.xsd EX-101.SCH 3265
4 XBRL DEFINITION FILE inm-20230925_def.xml EX-101.DEF 26195
5 XBRL LABEL FILE inm-20230925_lab.xml EX-101.LAB 35952
6 XBRL PRESENTATION FILE inm-20230925_pre.xml EX-101.PRE 24853
9 EXTRACTED XBRL INSTANCE DOCUMENT ea185755-8k_inmedpharm_htm.xml XML 4043
Mailing Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4
Business Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4 (604) 669-7207
InMed Pharmaceuticals Inc. (Filer) CIK: 0001728328 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-39685 | Film No.: 231275981
SIC: 2834 Pharmaceutical Preparations